APP and Alzheimer disease: This study aimed to investigate the effects of the protective PLCγ2-P522R variant on microglial responses and AD-related β-amyloid and neuronal pathologies as well as behavioral changes for the first time in a less aggressive APP/PS1 AD mouse model.